Assessment of the potentially decreased neutralizing activities of intravenous immunoglobulin against future coronavirus variants.

Inoue, Takamasa; Yunoki, Mikihiro; Kubota-Koketsu, Ritsuko; Shioda, Tatsuo

Inoue, Takamasa; Yunoki, Mikihiro; Kubota-Koketsu, Ritsuko; Shioda, Tatsuo.

Inoue T; Research and Development Division, Japan Blood Products Organization, Tokyo, Japan.
Yunoki M; Research and Development Division, Japan Blood Products Organization, Tokyo, Japan.
Kubota-Koketsu R; Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
Shioda T; Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

Transfusion ; 61(8): 2514-2515, 2021 08.

Article in English | MEDLINE | ID: covidwho-1344921

Subject(s)

Antibodies, Neutralizing/immunology; Antibodies, Viral/immunology; COVID-19/immunology; Immunoglobulins, Intravenous/immunology; SARS-CoV-2/immunology; Blood Donors; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulins, Intravenous / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / Antibodies, Viral Topics: Variants Limits: Humans Language: English Journal: Transfusion Year: 2021 Document Type: Article Affiliation country: Trf.16553

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google